Skip to main content
Top
Published in: Supportive Care in Cancer 4/2019

01-04-2019 | Breast Cancer | Original Article

Clinical and sociodemographic factors that may influence the resilience of women surviving breast cancer: cross-sectional study

Authors: María Padilla-Ruiz, Cristóbal Ruiz-Román, Elisabet Pérez-Ruiz, Antonio Rueda, Maximino Redondo, Francisco Rivas-Ruiz

Published in: Supportive Care in Cancer | Issue 4/2019

Login to get access

Abstract

Purpose

Breast cancer is one of the most common diseases, affecting many thousands of women. Although more than 80% of women survive the experience, very few studies have been conducted to examine the question of resilience among long-term survivors of breast cancer. The aim of this study is to describe the clinical and sociodemographic factors that correlate with greater resilience in women survivors of breast cancer, in the Costa del Sol Health Area (Spain).

Methods

Accordingly, a descriptive cross-sectional study was conducted, with respect to 59 survivors of breast cancer, who each completed a questionnaire for analysis according to the Connor-Davidson Resilience Scale (CD-RISC).

Results

The median resilience score was 77 (interquartile range 70–80). The group of patients who had survived for six or more years since the diagnosis had a higher score for total resilience (90: IR 76–92) than those diagnosed more recently (74: IR 65.7–83.7) (p = 0.012). Regarding the patients’ education background, the group with no formal qualifications or only primary studies had a score of 72 (IR 64–84), versus 79 (IR 74–89.7) for the group with higher levels of education (p = 0.016). Of the clinical variables, only the administration of chemotherapy was significantly associated with the score obtained on the CD-RISC scale (p = 0.012).

Conclusions

The results obtained in this study lead us to conclude that sociodemographic and clinical factors have a positive impact on the level of resilience among women resident in the Costa del Sol Health Area and who are long-term survivors of breast cancer.
Literature
2.
go back to reference Barnadas A, Algara M, Cordoba O, Casas A, Gonzalez M, Marzo M, Montero A, Muñoz M, Ruiz A, Santolaya F, Fernandez T (2017) Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish So. Clin Transl Oncol 20:687–694. https://doi.org/10.1007/s12094-017-1801-4 CrossRefPubMedPubMedCentral Barnadas A, Algara M, Cordoba O, Casas A, Gonzalez M, Marzo M, Montero A, Muñoz M, Ruiz A, Santolaya F, Fernandez T (2017) Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish So. Clin Transl Oncol 20:687–694. https://​doi.​org/​10.​1007/​s12094-017-1801-4 CrossRefPubMedPubMedCentral
14.
go back to reference Crespo M, Fernández-Lansac V, Soberón C (2014) Spanish version of the CD-RISC resilience scale for chronic stress situations. Behav Psychol 22:219–238 Crespo M, Fernández-Lansac V, Soberón C (2014) Spanish version of the CD-RISC resilience scale for chronic stress situations. Behav Psychol 22:219–238
22.
go back to reference Kim KJ, Conger RD, Elder GHJ, Lorenz FO (2003) Reciprocal influences between stressful life events and adolescent internalizing and externalizing problems. Child Dev 74:127–143CrossRefPubMed Kim KJ, Conger RD, Elder GHJ, Lorenz FO (2003) Reciprocal influences between stressful life events and adolescent internalizing and externalizing problems. Child Dev 74:127–143CrossRefPubMed
Metadata
Title
Clinical and sociodemographic factors that may influence the resilience of women surviving breast cancer: cross-sectional study
Authors
María Padilla-Ruiz
Cristóbal Ruiz-Román
Elisabet Pérez-Ruiz
Antonio Rueda
Maximino Redondo
Francisco Rivas-Ruiz
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4612-4

Other articles of this Issue 4/2019

Supportive Care in Cancer 4/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine